Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Unusually-High Trading Volume – Should You Buy?

Posted by Logan Wallace on Apr 2nd, 2026

Shares of Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) saw strong trading volume on Thursday . 281,087 shares traded hands during mid-day trading, an increase of 294% from the previous session’s volume of 71,377 shares.The stock last traded at $12.51 and had previously closed at $12.7250.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on FSNUY. Citigroup restated a “buy” rating on shares of Fresenius SE & Co. in a research note on Tuesday, February 3rd. Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a report on Monday, December 15th. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy”.

Check Out Our Latest Stock Report on Fresenius SE & Co.

Fresenius SE & Co. Trading Down 1.6%

The firm has a 50 day moving average of $14.13 and a 200 day moving average of $14.36. The firm has a market cap of $28.20 billion, a PE ratio of 19.87 and a beta of 0.75. The company has a quick ratio of 0.99, a current ratio of 1.26 and a debt-to-equity ratio of 0.49.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $0.28 earnings per share for the quarter. The company had revenue of $6.94 billion during the quarter. Fresenius SE & Co. had a return on equity of 10.38% and a net margin of 5.71%. Equities analysts anticipate that Fresenius SE & Co. will post 0.79 earnings per share for the current year.

Fresenius SE & Co. Company Profile

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.